Pharmafile Logo
Pharmafocus logo
Advanced Search
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

October 28, 2020
Research and Development

The coronavirus news this week focuses on clinical trials testing potential vaccines, with the University of Oxford and AstraZeneca stating …

News
pharmafocus_november_2020_cover

The November 2020 issue of Pharmafocus is available to read free online now!

October 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir

The latest monthly edition of Pharmafocus is available to read for free online now!

News
sanofi_hq__boetie_hall_web

Sanofi’s Dupixent shows strength at Phase 3 in eosinophilic esophagitis

October 27, 2020
Manufacturing and Production Dupixent, Sanofi, pharma

Sanofi has lifted the curtain on new Phase 3 data for Dupixent (dupilumab), showing that the drug met all of …

News
800px-eli_lilly_corporate_center_indianapolis_indiana_usa_2

Eli Lilly antibody treatment fails COVID-19 study

October 27, 2020
Manufacturing and Production

The US Government is putting an early end to clinical trials testing Eli Lilly’s antibody drug in COVID-19 patients.  The …

News
brain_mri_131749_t1

New trial to test if cancer drug can effectively treat hallucinations in Parkinson’s patients

October 27, 2020
Manufacturing and Production Parkinson's, Parkinson's UK

A new study is set to go ahead that will test if ondansetron is safe and effective in treating Parkinson’s …

News
800px-white_house_dc_2

US could have avoided over 130,000 COVID-19 deaths, according to a new study

October 27, 2020
Manufacturing and Production COVID, COVID-19, Trump, coronavirus

New studies suggest that the US could have avoided over 130,000 deaths if it responded earlier and in a coordinated …

News

Bayer buys out US-based Asklepios BioPharmaceutical in potential $4bn deal

October 26, 2020
Sales and Marketing Asklepios, Bayer, acquisition, pharma

Bayer has moved to bolster its cell and gene therapy (CGT) business through the acquisition of US biotech Asklepios BioPharmaceutical …

News
astrazeneca-sign

AstraZeneca’s COVID-19 vaccine generates immune response in both old and young participants

October 26, 2020
Research and Development, Sales and Marketing AstraZeneca, COVID-19, University of Oxford, Vaccine

AstraZeneca’s much-hyped COVID-19 vaccine candidate, AZD1222, currently in development in partnership with the University of Oxford, has shown promising immune …

News
800px-industria_novartis_1

Novartis announces positive Phase 2 data of rare renal disease therapy iptacopan

October 26, 2020
Sales and Marketing

Novartis has announced positive Phase 2 interim analysis results for iptacopan, which is an investigational oral treatment for rare renal …

News
706px-fentanyl_lollipops_actiq_400_mcg

UK Government outlines steps to tackle growing misuse of fentanyl

October 26, 2020
Sales and Marketing

The British Government has responded to a report investigating the misuse of fentanyl and painkillers in the UK. In January …

News
800px-who_flag_2

WHO warns regulators to consider all available evidence before approving remdesivir for COVID-19

October 26, 2020
Sales and Marketing COVID, COVID-19, Gilead, coronavirus

The World Health Organization’s Chief Scientist Soumya Swaminathan has warned that experts and regulators assessing the use of Gilead’s remdesivir …

News
me_and_calcin_at_aquarium_usa

Patient Experience: Living with Timothy syndrome

October 26, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Timoty syndrome, feature, patient experience, rare disease

Thirteen-year-old Calvin Muir lives with the ultra-rare genetic condition Timothy syndrome. Like many parents of rare disease patients, his mother …

Feature
brain_anatomy_medical_head_skull_digital_3_d_x_ray_xray_psychedelic_3720x2631_1

IBM and Pfizer designing AI model to predict onset of neurological diseases

October 23, 2020
Medical Communications

IBM has partnered with Pfizer to design an artificial intelligence model to predict the eventual onset of neurological diseases – …

News
fdaoutsideweb

FDA approves Gilead’s remdesivir for hospitalised COVID-19 patients

October 23, 2020
Medical Communications, Sales and Marketing COVID-19, FDA, Gilead, remdesivir

The FDA has approved Gilead’s antiviral therapy Veklury (remdesivir) for the treatment of hospitalised COVID-19 patients, making it the first …

News
nice_new_london_office_internal_3_web

Bayer’s Nubeqa secures NICE recommendation for hormone-relapsed prostate cancer at risk of metastasis

October 23, 2020
Medical Communications, Sales and Marketing Bayer, NCIE, Nubeqa, pharma

NICE has given its recommendation to Bayer’s androgen receptor inhibitor Nubeqa (darolutamide) in combination with androgen deprivation therapy (ADT) for …

News
generic-social-banners_v3_veeva-generic

Three Ways to Speed Your GxP Validation without Risk

October 23, 2020
Medical Communications, Research and Development

Computer system validation can often take months to complete. It typically involves infrastructure qualification (IQ), operational qualification (OQ), and performance …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

October 23, 2020
Medical Communications

The top ten news stories this week focus on coronavirus research, with the UK is set to be the first …

News
merck-keytruda

NICE recommends MSD’s Keytruda for untreated metastatic or unresectable recurrent head and neck squamous cell carcinoma

October 22, 2020
Sales and Marketing MSD, NCIE, NHS, keytruda

NICE has moved to recommend the use of MSD’s blockbuster immunotherapy drug Keytruda (pembrolizumab) as a monotherapy in the treatment …

News
gilead-sciences

Gilead’s Biktarvy proves non-inferior to standard care for HIV in Black and African American patients

October 22, 2020
Research and Development Biktarvy, Gilead, HIV, pharma

Gilead has revealed promising new Phase 3 data reinforcing the non-inferiority of Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg) compared to …

News
800px-european_commission_flags

The European Medicines Agency recommends 10 medicines for approval in October meeting

October 22, 2020
Research and Development

The EMA has recommended marketing authorisation for ten medicines and has also suggested ten label extensions.  The agency’s Committee for …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026